Concentric Analgesics, Inc. — Form D/A

Concentric Analgesics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2018-11-13. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2018-11-13
• Form: D/A
• Accession: 0001682398-18-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $20.0M
• Amount sold: $20.0M
• Investors: 109
• Date of first sale: 2018-07-18
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-318355

Issuer

• Name: Concentric Analgesics, Inc.
• CIK: 0001682398
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2014
• Address: 101 California Street, SAN FRANCISCO, CA, 94111
• Phone: 415-484-7921

Officers, directors & promoters (16)

Other filings by this issuer (8)

More

• CIK 1682398 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search